Selitrectinib Uses, Dosage, Side Effects and more
Selitrectinib is under investigation in clinical trial NCT03215511 (Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers).
| Attribute | Details |
|---|---|
| Trade Name | Selitrectinib |
| Generic | Selitrectinib |
| Selitrectinib Other Names | Selitrectinib |
| Type | |
| Formula | C20H21FN6O |
| Weight | Average: 380.427 Monoisotopic: 380.176087483 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
